|
|
Article: Orbus Signs Amitriptyline Licensing And Supply Agreements For Finland.
- Article from:
- M2 Presswire
- Article date:
- December 3, 2007
CopyrightCOPYRIGHT 2007 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-3 December 2007-Orbus Pharma Inc.: Orbus Signs Amitriptyline Licensing And Supply Agreements For Finland(C)1994-2007 M2 COMMUNICATIONS LTD
RDATE:30112007
Toronto, Ontario CANADA /FSC/ - Orbus Pharma Inc. (ORB - TSX), ("Orbus") today announced the signing of exclusive License and Supply Agreements for Amitriptyline in Finland. The agreements are with Algol Pharma OY, a pharmaceutical trading company based in Espoo Finland, and have an initial term of five years. Jeff Renwick, President and CEO of Orbus, stressed; "The signing of this agreement for Finland means agreements are now in place for three of the four major countries in the ...